

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | monoubiquitinated protein deubiquitination (GO:0035520) | 5.95409917 |
| 2 | nuclear pore complex assembly (GO:0051292) | 5.78586795 |
| 3 | nuclear pore organization (GO:0006999) | 5.62463615 |
| 4 | interkinetic nuclear migration (GO:0022027) | 5.50011986 |
| 5 | mitotic sister chromatid cohesion (GO:0007064) | 4.64227310 |
| 6 | establishment of protein localization to Golgi (GO:0072600) | 4.23470149 |
| 7 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 4.17803905 |
| 8 | neuron cell-cell adhesion (GO:0007158) | 4.14965952 |
| 9 | pore complex assembly (GO:0046931) | 4.08553375 |
| 10 | presynaptic membrane assembly (GO:0097105) | 4.06999308 |
| 11 | presynaptic membrane organization (GO:0097090) | 3.83989843 |
| 12 | protein targeting to Golgi (GO:0000042) | 3.81918006 |
| 13 | neural tube formation (GO:0001841) | 3.71204614 |
| 14 | central nervous system myelination (GO:0022010) | 3.70401745 |
| 15 | axon ensheathment in central nervous system (GO:0032291) | 3.70401745 |
| 16 | nucleus localization (GO:0051647) | 3.63104384 |
| 17 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.61812057 |
| 18 | regulation of RNA export from nucleus (GO:0046831) | 3.60514744 |
| 19 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.53138509 |
| 20 | Golgi to endosome transport (GO:0006895) | 3.44393796 |
| 21 | negative regulation of neurotransmitter transport (GO:0051589) | 3.44287754 |
| 22 | axonal fasciculation (GO:0007413) | 3.35422015 |
| 23 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.33544645 |
| 24 | neuron recognition (GO:0008038) | 3.30420912 |
| 25 | vocalization behavior (GO:0071625) | 3.28355687 |
| 26 | pericardium development (GO:0060039) | 3.24213143 |
| 27 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.22360090 |
| 28 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.22360090 |
| 29 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.22360090 |
| 30 | L-amino acid import (GO:0043092) | 3.22033885 |
| 31 | interleukin-6-mediated signaling pathway (GO:0070102) | 3.21698166 |
| 32 | transmission of nerve impulse (GO:0019226) | 3.19144186 |
| 33 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.18262111 |
| 34 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.17806185 |
| 35 | cyclic nucleotide catabolic process (GO:0009214) | 3.16910210 |
| 36 | microtubule anchoring (GO:0034453) | 3.13883793 |
| 37 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 3.12206247 |
| 38 | startle response (GO:0001964) | 3.11525331 |
| 39 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.10528280 |
| 40 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 3.06681893 |
| 41 | cAMP catabolic process (GO:0006198) | 3.05111737 |
| 42 | retina layer formation (GO:0010842) | 3.01686470 |
| 43 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.00858620 |
| 44 | mechanosensory behavior (GO:0007638) | 3.00048404 |
| 45 | protein localization to synapse (GO:0035418) | 2.99879906 |
| 46 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.97306066 |
| 47 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.96043134 |
| 48 | protein K48-linked deubiquitination (GO:0071108) | 2.95156760 |
| 49 | keratinocyte development (GO:0003334) | 2.93371764 |
| 50 | neuronal ion channel clustering (GO:0045161) | 2.92394794 |
| 51 | auditory behavior (GO:0031223) | 2.92208981 |
| 52 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.90770364 |
| 53 | negative regulation of DNA repair (GO:0045738) | 2.89424827 |
| 54 | cellular response to ethanol (GO:0071361) | 2.89130282 |
| 55 | histone H3-K4 trimethylation (GO:0080182) | 2.87294158 |
| 56 | protein K11-linked deubiquitination (GO:0035871) | 2.86729735 |
| 57 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.86728045 |
| 58 | locomotory exploration behavior (GO:0035641) | 2.86163608 |
| 59 | glutamate receptor signaling pathway (GO:0007215) | 2.84313622 |
| 60 | sister chromatid cohesion (GO:0007062) | 2.83821311 |
| 61 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.83419964 |
| 62 | protein targeting to vacuole (GO:0006623) | 2.82179351 |
| 63 | protein targeting to lysosome (GO:0006622) | 2.82179351 |
| 64 | establishment of protein localization to vacuole (GO:0072666) | 2.82179351 |
| 65 | iron ion import (GO:0097286) | 2.81142459 |
| 66 | positive regulation of developmental pigmentation (GO:0048087) | 2.80010885 |
| 67 | prenylation (GO:0097354) | 2.79535690 |
| 68 | protein prenylation (GO:0018342) | 2.79535690 |
| 69 | regulation of sarcomere organization (GO:0060297) | 2.79403395 |
| 70 | regulation of relaxation of muscle (GO:1901077) | 2.78006735 |
| 71 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.77804287 |
| 72 | regulation of establishment of cell polarity (GO:2000114) | 2.77264198 |
| 73 | regulation of protein polyubiquitination (GO:1902914) | 2.74713477 |
| 74 | dendrite morphogenesis (GO:0048813) | 2.73420659 |
| 75 | peptidyl-lysine trimethylation (GO:0018023) | 2.73264013 |
| 76 | muscle atrophy (GO:0014889) | 2.73233022 |
| 77 | regulation of pigment cell differentiation (GO:0050932) | 2.70965466 |
| 78 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.70281292 |
| 79 | synaptic transmission, glutamatergic (GO:0035249) | 2.68767532 |
| 80 | early endosome to late endosome transport (GO:0045022) | 2.67372623 |
| 81 | ER overload response (GO:0006983) | 2.67319877 |
| 82 | skeletal muscle adaptation (GO:0043501) | 2.67187114 |
| 83 | cell wall macromolecule catabolic process (GO:0016998) | 2.66853939 |
| 84 | myelin assembly (GO:0032288) | 2.66400981 |
| 85 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.65298736 |
| 86 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.65221037 |
| 87 | striated muscle atrophy (GO:0014891) | 2.65161012 |
| 88 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.64928499 |
| 89 | regulation of protein glycosylation (GO:0060049) | 2.63842849 |
| 90 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.63368487 |
| 91 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.61478996 |
| 92 | photoreceptor cell differentiation (GO:0046530) | 2.61106638 |
| 93 | eye photoreceptor cell differentiation (GO:0001754) | 2.61106638 |
| 94 | regulation of DNA endoreduplication (GO:0032875) | 2.60553140 |
| 95 | asymmetric protein localization (GO:0008105) | 2.59966805 |
| 96 | neuron-neuron synaptic transmission (GO:0007270) | 2.59029215 |
| 97 | protein localization to Golgi apparatus (GO:0034067) | 2.57903335 |
| 98 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.57422158 |
| 99 | establishment of nucleus localization (GO:0040023) | 2.56596483 |
| 100 | pre-miRNA processing (GO:0031054) | 2.56284540 |
| 101 | establishment of mitochondrion localization (GO:0051654) | 2.54006415 |
| 102 | Notch signaling involved in heart development (GO:0061314) | 2.53620764 |
| 103 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.52687191 |
| 104 | myofibril assembly (GO:0030239) | 2.52627169 |
| 105 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.52391776 |
| 106 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.52391776 |
| 107 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.52391776 |
| 108 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.52331772 |
| 109 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.52290948 |
| 110 | regulation of feeding behavior (GO:0060259) | 2.52251833 |
| 111 | regulation of meiosis I (GO:0060631) | 2.51616349 |
| 112 | histone mRNA catabolic process (GO:0071044) | 2.51448264 |
| 113 | myelination (GO:0042552) | 2.51140509 |
| 114 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.50799828 |
| 115 | positive regulation of synapse assembly (GO:0051965) | 2.50394498 |
| 116 | central nervous system neuron axonogenesis (GO:0021955) | 2.50322348 |
| 117 | histone H3-K36 demethylation (GO:0070544) | 2.49860240 |
| 118 | macroautophagy (GO:0016236) | 2.49731079 |
| 119 | protein deubiquitination (GO:0016579) | 2.49650964 |
| 120 | synapse assembly (GO:0007416) | 2.49269356 |
| 121 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.48940170 |
| 122 | gamma-aminobutyric acid transport (GO:0015812) | 2.48536050 |
| 123 | synaptic vesicle maturation (GO:0016188) | 2.47944699 |
| 124 | nucleus organization (GO:0006997) | 2.47929796 |
| 125 | mRNA splice site selection (GO:0006376) | 2.47556011 |
| 126 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.46214802 |
| 127 | dendritic spine morphogenesis (GO:0060997) | 2.45561268 |
| 128 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.45146613 |
| 129 | phospholipid translocation (GO:0045332) | 2.44939353 |
| 130 | lipid translocation (GO:0034204) | 2.44939353 |
| 131 | detection of calcium ion (GO:0005513) | 2.44248275 |
| 132 | glycoprotein catabolic process (GO:0006516) | 2.43399135 |
| 133 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.42952531 |
| 134 | postsynaptic membrane organization (GO:0001941) | 2.42628078 |
| 135 | righting reflex (GO:0060013) | 2.41650696 |
| 136 | regulation of centriole replication (GO:0046599) | 2.41357101 |
| 137 | secondary heart field specification (GO:0003139) | 2.40811067 |
| 138 | heart field specification (GO:0003128) | 2.40811067 |
| 139 | amino acid import (GO:0043090) | 2.39639040 |
| 140 | synaptic vesicle exocytosis (GO:0016079) | 2.39503414 |
| 141 | axon ensheathment (GO:0008366) | 2.39369616 |
| 142 | ensheathment of neurons (GO:0007272) | 2.39369616 |
| 143 | regulation of cell communication by electrical coupling (GO:0010649) | 2.38509694 |
| 144 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.38422964 |
| 145 | vesicle transport along microtubule (GO:0047496) | 2.38182880 |
| 146 | N-terminal protein amino acid acetylation (GO:0006474) | 2.38091110 |
| 147 | peptidyl-threonine phosphorylation (GO:0018107) | 2.37570595 |
| 148 | negative regulation of axon extension (GO:0030517) | 2.37007019 |
| 149 | negative regulation of meiosis (GO:0045835) | 2.36320861 |
| 150 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.36250412 |
| 151 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.35517873 |
| 152 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.35246211 |
| 153 | regulation of synapse assembly (GO:0051963) | 2.35083235 |
| 154 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.35069488 |
| 155 | peptidyl-threonine modification (GO:0018210) | 2.34863234 |
| 156 | peptidyl-lysine methylation (GO:0018022) | 2.34035483 |
| 157 | mRNA modification (GO:0016556) | 2.33796264 |
| 158 | protein K63-linked deubiquitination (GO:0070536) | 2.33170815 |
| 159 | interferon-gamma production (GO:0032609) | 2.32842026 |
| 160 | cardiac myofibril assembly (GO:0055003) | 2.32507343 |
| 161 | regulation of respiratory system process (GO:0044065) | 2.32152961 |
| 162 | synapse organization (GO:0050808) | 2.32043705 |
| 163 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.31896443 |
| 164 | positive regulation of muscle hypertrophy (GO:0014742) | 2.31803244 |
| 165 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.31803244 |
| 166 | limb bud formation (GO:0060174) | 2.31724459 |
| 167 | actin-mediated cell contraction (GO:0070252) | 2.31644299 |
| 168 | definitive hemopoiesis (GO:0060216) | 2.31380226 |
| 169 | regulation of respiratory gaseous exchange (GO:0043576) | 2.30928539 |
| 170 | peripheral nervous system axon ensheathment (GO:0032292) | 2.30661964 |
| 171 | myelination in peripheral nervous system (GO:0022011) | 2.30661964 |
| 172 | cell differentiation in hindbrain (GO:0021533) | 2.30202169 |
| 173 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.30060226 |
| 174 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.30035294 |
| 175 | response to auditory stimulus (GO:0010996) | 2.29466642 |
| 176 | glomerulus development (GO:0032835) | 2.28737038 |
| 177 | developmental pigmentation (GO:0048066) | 2.28376010 |
| 178 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.28299778 |
| 179 | regulation of axon guidance (GO:1902667) | 2.26584256 |
| 180 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.26281600 |
| 181 | neuronal action potential propagation (GO:0019227) | 2.25426694 |
| 182 | cAMP metabolic process (GO:0046058) | 2.25118100 |
| 183 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.24935742 |
| 184 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.24879120 |
| 185 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.24879120 |
| 186 | regulation of postsynaptic membrane potential (GO:0060078) | 2.24661609 |
| 187 | import into cell (GO:0098657) | 2.24655951 |
| 188 | nerve growth factor signaling pathway (GO:0038180) | 2.23820032 |
| 189 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.22969248 |
| 190 | regulation of somitogenesis (GO:0014807) | 2.22755550 |
| 191 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.22630106 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.04338026 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.38473108 |
| 3 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.72802539 |
| 4 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.63278290 |
| 5 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.56002008 |
| 6 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.51249206 |
| 7 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.31543599 |
| 8 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.21943327 |
| 9 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.21795824 |
| 10 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.16721624 |
| 11 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.13837827 |
| 12 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.13402508 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.06700236 |
| 14 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 2.05917656 |
| 15 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.00315472 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.98271151 |
| 17 | P300_19829295_ChIP-Seq_ESCs_Human | 1.97298144 |
| 18 | FUS_26573619_Chip-Seq_HEK293_Human | 1.92010148 |
| 19 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.86188902 |
| 20 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.84095092 |
| 21 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.83686307 |
| 22 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.82331343 |
| 23 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.82288977 |
| 24 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.81433886 |
| 25 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.80708883 |
| 26 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.79281227 |
| 27 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.78690690 |
| 28 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.74445177 |
| 29 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.73043158 |
| 30 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.72932519 |
| 31 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.71890217 |
| 32 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.71890217 |
| 33 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.71125686 |
| 34 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.68762129 |
| 35 | TP53_16413492_ChIP-PET_HCT116_Human | 1.68110457 |
| 36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.67418240 |
| 37 | STAT3_23295773_ChIP-Seq_U87_Human | 1.67042180 |
| 38 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.66971407 |
| 39 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.66734383 |
| 40 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.66636562 |
| 41 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.62624764 |
| 42 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.61540155 |
| 43 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.61129105 |
| 44 | EWS_26573619_Chip-Seq_HEK293_Human | 1.61095379 |
| 45 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.61024541 |
| 46 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.58591855 |
| 47 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.58582624 |
| 48 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.56110562 |
| 49 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.56004266 |
| 50 | VDR_22108803_ChIP-Seq_LS180_Human | 1.53894218 |
| 51 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.53039823 |
| 52 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.50704274 |
| 53 | TCF4_23295773_ChIP-Seq_U87_Human | 1.48461780 |
| 54 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.46240701 |
| 55 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.44065613 |
| 56 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.42304203 |
| 57 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.42057324 |
| 58 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.41912122 |
| 59 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.41425732 |
| 60 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.41413703 |
| 61 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.40784717 |
| 62 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.40259924 |
| 63 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.40259924 |
| 64 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.40028007 |
| 65 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.38957374 |
| 66 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.38936793 |
| 67 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.37776514 |
| 68 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.35724054 |
| 69 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.34965371 |
| 70 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.34289957 |
| 71 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.31316299 |
| 72 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.30539951 |
| 73 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.30528497 |
| 74 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29545455 |
| 75 | AR_25329375_ChIP-Seq_VCAP_Human | 1.28661993 |
| 76 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.28523513 |
| 77 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.28266158 |
| 78 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.27759640 |
| 79 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.27674159 |
| 80 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.27316780 |
| 81 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.26794133 |
| 82 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.26592444 |
| 83 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.26283354 |
| 84 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.26042263 |
| 85 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.25732194 |
| 86 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.25429398 |
| 87 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.25170628 |
| 88 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.23782157 |
| 89 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.21674584 |
| 90 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.21310896 |
| 91 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.21263456 |
| 92 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.21127687 |
| 93 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.20527964 |
| 94 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.19665866 |
| 95 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.19632734 |
| 96 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19229817 |
| 97 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.19229817 |
| 98 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.18350299 |
| 99 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.17469886 |
| 100 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.17339802 |
| 101 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.17318924 |
| 102 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.16964335 |
| 103 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.16527375 |
| 104 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.15752660 |
| 105 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.15354250 |
| 106 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.15210969 |
| 107 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.15089174 |
| 108 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.14919111 |
| 109 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.14238373 |
| 110 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.13851526 |
| 111 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.13760022 |
| 112 | GATA1_22025678_ChIP-Seq_K562_Human | 1.13430524 |
| 113 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.12969974 |
| 114 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.12194707 |
| 115 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.12037699 |
| 116 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09884731 |
| 117 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.09817743 |
| 118 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.09193947 |
| 119 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.08007747 |
| 120 | RXR_22108803_ChIP-Seq_LS180_Human | 1.07893461 |
| 121 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.07393070 |
| 122 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.07393070 |
| 123 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.06264751 |
| 124 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.05357586 |
| 125 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.05157987 |
| 126 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.04813883 |
| 127 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.02988136 |
| 128 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.01563380 |
| 129 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.01055334 |
| 130 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00105243 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008057_abnormal_DNA_replication | 4.78002838 |
| 2 | MP0004084_abnormal_cardiac_muscle | 3.66555029 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 3.50579986 |
| 4 | MP0005409_darkened_coat_color | 3.45666816 |
| 5 | MP0003880_abnormal_central_pattern | 3.44885641 |
| 6 | MP0003787_abnormal_imprinting | 3.19653273 |
| 7 | MP0004859_abnormal_synaptic_plasticity | 3.13616525 |
| 8 | MP0005171_absent_coat_pigmentation | 2.99130327 |
| 9 | MP0001188_hyperpigmentation | 2.84077720 |
| 10 | MP0000569_abnormal_digit_pigmentation | 2.60760134 |
| 11 | MP0003635_abnormal_synaptic_transmissio | 2.56079069 |
| 12 | MP0004036_abnormal_muscle_relaxation | 2.53372204 |
| 13 | MP0004270_analgesia | 2.51876909 |
| 14 | MP0004215_abnormal_myocardial_fiber | 2.42432191 |
| 15 | MP0009745_abnormal_behavioral_response | 2.37443569 |
| 16 | MP0010352_gastrointestinal_tract_polyps | 2.29037140 |
| 17 | MP0001486_abnormal_startle_reflex | 2.19850016 |
| 18 | MP0000778_abnormal_nervous_system | 2.14806782 |
| 19 | MP0002064_seizures | 2.08468772 |
| 20 | MP0002272_abnormal_nervous_system | 2.01038025 |
| 21 | MP0005174_abnormal_tail_pigmentation | 1.99460108 |
| 22 | * MP0002063_abnormal_learning/memory/cond | 1.96473512 |
| 23 | MP0001968_abnormal_touch/_nociception | 1.94095273 |
| 24 | * MP0002572_abnormal_emotion/affect_behav | 1.88590914 |
| 25 | MP0002009_preneoplasia | 1.84506986 |
| 26 | MP0000920_abnormal_myelination | 1.84097461 |
| 27 | MP0000566_synostosis | 1.80032357 |
| 28 | MP0008775_abnormal_heart_ventricle | 1.78097575 |
| 29 | MP0003221_abnormal_cardiomyocyte_apopto | 1.76349147 |
| 30 | MP0005646_abnormal_pituitary_gland | 1.74940211 |
| 31 | MP0009046_muscle_twitch | 1.73502777 |
| 32 | MP0002735_abnormal_chemical_nociception | 1.72494857 |
| 33 | MP0001177_atelectasis | 1.71844415 |
| 34 | MP0003941_abnormal_skin_development | 1.66405828 |
| 35 | MP0003656_abnormal_erythrocyte_physiolo | 1.66018890 |
| 36 | MP0000015_abnormal_ear_pigmentation | 1.63123154 |
| 37 | MP0008569_lethality_at_weaning | 1.62176422 |
| 38 | MP0003646_muscle_fatigue | 1.59912457 |
| 39 | MP0002067_abnormal_sensory_capabilities | 1.59527745 |
| 40 | MP0002734_abnormal_mechanical_nocicepti | 1.57534913 |
| 41 | MP0002822_catalepsy | 1.57412118 |
| 42 | MP0004742_abnormal_vestibular_system | 1.55742175 |
| 43 | MP0005551_abnormal_eye_electrophysiolog | 1.53019673 |
| 44 | MP0005423_abnormal_somatic_nervous | 1.52672636 |
| 45 | MP0004924_abnormal_behavior | 1.49571041 |
| 46 | MP0005386_behavior/neurological_phenoty | 1.49571041 |
| 47 | MP0002557_abnormal_social/conspecific_i | 1.48713751 |
| 48 | MP0009697_abnormal_copulation | 1.46923737 |
| 49 | MP0005187_abnormal_penis_morphology | 1.45974101 |
| 50 | MP0000749_muscle_degeneration | 1.45133607 |
| 51 | MP0000427_abnormal_hair_cycle | 1.44383281 |
| 52 | MP0002736_abnormal_nociception_after | 1.42687317 |
| 53 | MP0002396_abnormal_hematopoietic_system | 1.40178570 |
| 54 | MP0000631_abnormal_neuroendocrine_gland | 1.36793853 |
| 55 | MP0000371_diluted_coat_color | 1.36583050 |
| 56 | MP0002006_tumorigenesis | 1.36208685 |
| 57 | MP0001502_abnormal_circadian_rhythm | 1.35858972 |
| 58 | MP0003121_genomic_imprinting | 1.35444488 |
| 59 | MP0001501_abnormal_sleep_pattern | 1.34624252 |
| 60 | MP0005503_abnormal_tendon_morphology | 1.33613265 |
| 61 | MP0004145_abnormal_muscle_electrophysio | 1.33394934 |
| 62 | MP0010678_abnormal_skin_adnexa | 1.33166599 |
| 63 | MP0010307_abnormal_tumor_latency | 1.31349488 |
| 64 | MP0002184_abnormal_innervation | 1.31167588 |
| 65 | MP0010234_abnormal_vibrissa_follicle | 1.30749804 |
| 66 | MP0003943_abnormal_hepatobiliary_system | 1.29253917 |
| 67 | MP0001529_abnormal_vocalization | 1.28858133 |
| 68 | MP0005645_abnormal_hypothalamus_physiol | 1.28040972 |
| 69 | MP0001440_abnormal_grooming_behavior | 1.27880212 |
| 70 | MP0003632_abnormal_nervous_system | 1.25160037 |
| 71 | MP0001879_abnormal_lymphatic_vessel | 1.23547978 |
| 72 | MP0005275_abnormal_skin_tensile | 1.23501481 |
| 73 | MP0006138_congestive_heart_failure | 1.22870177 |
| 74 | MP0002168_other_aberrant_phenotype | 1.22535225 |
| 75 | MP0002938_white_spotting | 1.22477330 |
| 76 | MP0002088_abnormal_embryonic_growth/wei | 1.22033668 |
| 77 | MP0000955_abnormal_spinal_cord | 1.21074753 |
| 78 | MP0006054_spinal_hemorrhage | 1.20188320 |
| 79 | MP0003122_maternal_imprinting | 1.20165438 |
| 80 | MP0004134_abnormal_chest_morphology | 1.20150873 |
| 81 | MP0000383_abnormal_hair_follicle | 1.19667928 |
| 82 | MP0004233_abnormal_muscle_weight | 1.17434710 |
| 83 | MP0008438_abnormal_cutaneous_collagen | 1.17133134 |
| 84 | * MP0002882_abnormal_neuron_morphology | 1.16551097 |
| 85 | MP0004811_abnormal_neuron_physiology | 1.15076641 |
| 86 | MP0003631_nervous_system_phenotype | 1.14692151 |
| 87 | MP0009780_abnormal_chondrocyte_physiolo | 1.14622155 |
| 88 | MP0003633_abnormal_nervous_system | 1.14430367 |
| 89 | MP0003984_embryonic_growth_retardation | 1.13301428 |
| 90 | MP0001905_abnormal_dopamine_level | 1.12831703 |
| 91 | MP0004885_abnormal_endolymph | 1.11650481 |
| 92 | MP0003690_abnormal_glial_cell | 1.11486544 |
| 93 | MP0003136_yellow_coat_color | 1.11371753 |
| 94 | MP0004484_altered_response_of | 1.09747621 |
| 95 | MP0002166_altered_tumor_susceptibility | 1.09489065 |
| 96 | MP0005310_abnormal_salivary_gland | 1.08077694 |
| 97 | MP0002108_abnormal_muscle_morphology | 1.07855978 |
| 98 | MP0006276_abnormal_autonomic_nervous | 1.06420345 |
| 99 | MP0010368_abnormal_lymphatic_system | 1.06417181 |
| 100 | MP0005620_abnormal_muscle_contractility | 1.06357123 |
| 101 | MP0001984_abnormal_olfaction | 1.06046822 |
| 102 | MP0001661_extended_life_span | 1.05540801 |
| 103 | MP0000751_myopathy | 1.03889575 |
| 104 | MP0002733_abnormal_thermal_nociception | 1.02184083 |
| 105 | MP0003828_pulmonary_edema | 1.01111136 |
| 106 | MP0006072_abnormal_retinal_apoptosis | 1.00955428 |
| 107 | MP0001672_abnormal_embryogenesis/_devel | 1.00308144 |
| 108 | MP0005380_embryogenesis_phenotype | 1.00308144 |
| 109 | MP0002084_abnormal_developmental_patter | 0.99888110 |
| 110 | MP0001970_abnormal_pain_threshold | 0.99824318 |
| 111 | * MP0002066_abnormal_motor_capabilities/c | 0.99286096 |
| 112 | MP0009703_decreased_birth_body | 0.99134914 |
| 113 | MP0010094_abnormal_chromosome_stability | 0.98835207 |
| 114 | MP0002972_abnormal_cardiac_muscle | 0.98685079 |
| 115 | MP0001299_abnormal_eye_distance/ | 0.98159105 |
| 116 | * MP0002152_abnormal_brain_morphology | 0.98072030 |
| 117 | MP0005623_abnormal_meninges_morphology | 0.97498469 |
| 118 | MP0004808_abnormal_hematopoietic_stem | 0.95367864 |
| 119 | MP0000516_abnormal_urinary_system | 0.95179479 |
| 120 | MP0005367_renal/urinary_system_phenotyp | 0.95179479 |
| 121 | MP0002177_abnormal_outer_ear | 0.95010337 |
| 122 | MP0002106_abnormal_muscle_physiology | 0.94959582 |
| 123 | MP0005395_other_phenotype | 0.94040507 |
| 124 | MP0004087_abnormal_muscle_fiber | 0.93999168 |
| 125 | MP0002127_abnormal_cardiovascular_syste | 0.93795073 |
| 126 | MP0002332_abnormal_exercise_endurance | 0.92784249 |
| 127 | MP0008877_abnormal_DNA_methylation | 0.92000759 |
| 128 | MP0004272_abnormal_basement_membrane | 0.91748968 |
| 129 | MP0003045_fibrosis | 0.90633129 |
| 130 | MP0005253_abnormal_eye_physiology | 0.87976412 |
| 131 | MP0004142_abnormal_muscle_tone | 0.87204180 |
| 132 | * MP0002086_abnormal_extraembryonic_tissu | 0.86774377 |
| 133 | MP0002229_neurodegeneration | 0.86394833 |
| 134 | MP0003950_abnormal_plasma_membrane | 0.86247772 |
| 135 | MP0002269_muscular_atrophy | 0.86170736 |
| 136 | MP0004130_abnormal_muscle_cell | 0.86152644 |
| 137 | MP0006292_abnormal_olfactory_placode | 0.85706955 |
| 138 | MP0008058_abnormal_DNA_repair | 0.85626539 |
| 139 | MP0001963_abnormal_hearing_physiology | 0.85220326 |
| 140 | MP0005266_abnormal_metabolism | 0.85176854 |
| 141 | MP0000013_abnormal_adipose_tissue | 0.84989974 |
| 142 | MP0003634_abnormal_glial_cell | 0.84331731 |
| 143 | MP0001191_abnormal_skin_condition | 0.82672665 |
| 144 | * MP0001784_abnormal_fluid_regulation | 0.80309959 |
| 145 | MP0000372_irregular_coat_pigmentation | 0.79113810 |
| 146 | MP0002752_abnormal_somatic_nervous | 0.78723109 |
| 147 | * MP0000266_abnormal_heart_morphology | 0.77728675 |
| 148 | MP0003890_abnormal_embryonic-extraembry | 0.76561946 |
| 149 | MP0004085_abnormal_heartbeat | 0.76294240 |
| 150 | MP0005076_abnormal_cell_differentiation | 0.76277897 |
| 151 | MP0000733_abnormal_muscle_development | 0.76203314 |
| 152 | MP0003566_abnormal_cell_adhesion | 0.75786791 |
| 153 | MP0003935_abnormal_craniofacial_develop | 0.75543492 |
| 154 | MP0003786_premature_aging | 0.75209590 |
| 155 | MP0002075_abnormal_coat/hair_pigmentati | 0.74609123 |
| 156 | MP0000003_abnormal_adipose_tissue | 0.73752919 |
| 157 | MP0004147_increased_porphyrin_level | 0.73702348 |
| 158 | MP0003937_abnormal_limbs/digits/tail_de | 0.73697990 |
| 159 | MP0005369_muscle_phenotype | 0.73247896 |
| 160 | MP0001943_abnormal_respiration | 0.72887087 |
| 161 | MP0008995_early_reproductive_senescence | 0.72199357 |
| 162 | MP0002133_abnormal_respiratory_system | 0.71934391 |
| 163 | MP0005388_respiratory_system_phenotype | 0.71934391 |
| 164 | * MP0002925_abnormal_cardiovascular_devel | 0.70742558 |
| 165 | MP0003567_abnormal_fetal_cardiomyocyte | 0.69480511 |
| 166 | * MP0010630_abnormal_cardiac_muscle | 0.69397569 |
| 167 | MP0002095_abnormal_skin_pigmentation | 0.69319457 |
| 168 | MP0001485_abnormal_pinna_reflex | 0.68696577 |
| 169 | MP0003385_abnormal_body_wall | 0.67010267 |
| 170 | MP0003718_maternal_effect | 0.66967526 |
| 171 | MP0000432_abnormal_head_morphology | 0.66303936 |
| 172 | MP0008961_abnormal_basal_metabolism | 0.65977583 |
| 173 | * MP0003861_abnormal_nervous_system | 0.65228275 |
| 174 | MP0000428_abnormal_craniofacial_morphol | 0.64955631 |
| 175 | MP0001186_pigmentation_phenotype | 0.64837862 |
| 176 | MP0005195_abnormal_posterior_eye | 0.63979097 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 3.72064066 |
| 2 | Thyroid carcinoma (HP:0002890) | 3.45440230 |
| 3 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.44903123 |
| 4 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.44903123 |
| 5 | Protruding tongue (HP:0010808) | 3.39652242 |
| 6 | Focal seizures (HP:0007359) | 3.34578724 |
| 7 | Febrile seizures (HP:0002373) | 3.28103467 |
| 8 | Hyperventilation (HP:0002883) | 3.26048368 |
| 9 | Blue irides (HP:0000635) | 3.06499319 |
| 10 | Abnormality of the ischium (HP:0003174) | 3.06124743 |
| 11 | Horizontal nystagmus (HP:0000666) | 3.03483330 |
| 12 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.89611910 |
| 13 | Subaortic stenosis (HP:0001682) | 2.89611910 |
| 14 | Atonic seizures (HP:0010819) | 2.85629838 |
| 15 | Hypoplastic ischia (HP:0003175) | 2.80758353 |
| 16 | Abnormality of the nasal septum (HP:0000419) | 2.80746590 |
| 17 | Abnormality of incisor morphology (HP:0011063) | 2.80119903 |
| 18 | Broad-based gait (HP:0002136) | 2.76506508 |
| 19 | Volvulus (HP:0002580) | 2.76029707 |
| 20 | Abnormality of the corticospinal tract (HP:0002492) | 2.68352691 |
| 21 | Epileptic encephalopathy (HP:0200134) | 2.67321125 |
| 22 | Cupped ear (HP:0000378) | 2.65343542 |
| 23 | Cystic hygroma (HP:0000476) | 2.65306487 |
| 24 | Intestinal atresia (HP:0011100) | 2.62401020 |
| 25 | Long clavicles (HP:0000890) | 2.60919700 |
| 26 | Chronic hepatic failure (HP:0100626) | 2.60281767 |
| 27 | Truncal ataxia (HP:0002078) | 2.60106257 |
| 28 | Absent speech (HP:0001344) | 2.57364046 |
| 29 | Tubulointerstitial nephritis (HP:0001970) | 2.55751272 |
| 30 | Rhabdomyosarcoma (HP:0002859) | 2.50579138 |
| 31 | Low anterior hairline (HP:0000294) | 2.45252177 |
| 32 | Abnormal biliary tract morphology (HP:0012440) | 2.44759923 |
| 33 | Gaze-evoked nystagmus (HP:0000640) | 2.42349431 |
| 34 | Glioma (HP:0009733) | 2.40748141 |
| 35 | Hyperkalemia (HP:0002153) | 2.37821923 |
| 36 | Ependymoma (HP:0002888) | 2.36962434 |
| 37 | Aqueductal stenosis (HP:0002410) | 2.35046282 |
| 38 | Biliary tract neoplasm (HP:0100574) | 2.32564281 |
| 39 | Thickened helices (HP:0000391) | 2.32539147 |
| 40 | Widely spaced teeth (HP:0000687) | 2.31271446 |
| 41 | Astrocytoma (HP:0009592) | 2.30359282 |
| 42 | Abnormality of the astrocytes (HP:0100707) | 2.30359282 |
| 43 | Gastroesophageal reflux (HP:0002020) | 2.30354327 |
| 44 | Drooling (HP:0002307) | 2.29471769 |
| 45 | Excessive salivation (HP:0003781) | 2.29471769 |
| 46 | Decreased circulating renin level (HP:0003351) | 2.24764931 |
| 47 | Abnormality of the renal cortex (HP:0011035) | 2.24416508 |
| 48 | Tented upper lip vermilion (HP:0010804) | 2.23818932 |
| 49 | * Fair hair (HP:0002286) | 2.20782488 |
| 50 | Heterotopia (HP:0002282) | 2.20495498 |
| 51 | Short chin (HP:0000331) | 2.20459533 |
| 52 | Absence seizures (HP:0002121) | 2.16614811 |
| 53 | Macroorchidism (HP:0000053) | 2.15984826 |
| 54 | * Generalized hypopigmentation of hair (HP:0011358) | 2.15285849 |
| 55 | Renal cortical cysts (HP:0000803) | 2.15072657 |
| 56 | Exotropia (HP:0000577) | 2.13217805 |
| 57 | Scanning speech (HP:0002168) | 2.13066736 |
| 58 | Papillary thyroid carcinoma (HP:0002895) | 2.12792515 |
| 59 | Progressive cerebellar ataxia (HP:0002073) | 2.12214441 |
| 60 | Dialeptic seizures (HP:0011146) | 2.11620119 |
| 61 | Abnormality of chromosome stability (HP:0003220) | 2.11610568 |
| 62 | Sensory axonal neuropathy (HP:0003390) | 2.11156941 |
| 63 | Alacrima (HP:0000522) | 2.09726777 |
| 64 | Visual hallucinations (HP:0002367) | 2.09160503 |
| 65 | Medulloblastoma (HP:0002885) | 2.08747196 |
| 66 | Curly hair (HP:0002212) | 2.07642742 |
| 67 | Abnormal auditory evoked potentials (HP:0006958) | 2.07224699 |
| 68 | Nemaline bodies (HP:0003798) | 2.03432201 |
| 69 | Neoplasm of the small intestine (HP:0100833) | 2.03255426 |
| 70 | Abnormality of the right ventricle (HP:0001707) | 2.02848365 |
| 71 | Absent frontal sinuses (HP:0002688) | 2.02043653 |
| 72 | Acute myeloid leukemia (HP:0004808) | 2.00477338 |
| 73 | Sandal gap (HP:0001852) | 2.00416875 |
| 74 | Thick eyebrow (HP:0000574) | 2.00333699 |
| 75 | Spastic gait (HP:0002064) | 1.98640944 |
| 76 | Calf muscle hypertrophy (HP:0008981) | 1.98513777 |
| 77 | Molar tooth sign on MRI (HP:0002419) | 1.97948573 |
| 78 | Abnormality of midbrain morphology (HP:0002418) | 1.97948573 |
| 79 | Bell-shaped thorax (HP:0001591) | 1.97764123 |
| 80 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.97690195 |
| 81 | Open mouth (HP:0000194) | 1.96946379 |
| 82 | Abnormality of salivation (HP:0100755) | 1.96793591 |
| 83 | Hypoplastic labia majora (HP:0000059) | 1.96128856 |
| 84 | Submucous cleft hard palate (HP:0000176) | 1.96018434 |
| 85 | Muscle fiber inclusion bodies (HP:0100299) | 1.95800704 |
| 86 | Portal hypertension (HP:0001409) | 1.95397427 |
| 87 | Poikilocytosis (HP:0004447) | 1.93485306 |
| 88 | Neoplasm of striated muscle (HP:0009728) | 1.93076876 |
| 89 | Abnormality of the epiphyses of the hand (HP:0005924) | 1.92108862 |
| 90 | Lip pit (HP:0100267) | 1.92081339 |
| 91 | Decreased lacrimation (HP:0000633) | 1.92013261 |
| 92 | Buphthalmos (HP:0000557) | 1.91764239 |
| 93 | Hip dysplasia (HP:0001385) | 1.88776823 |
| 94 | Stomach cancer (HP:0012126) | 1.88112934 |
| 95 | Abnormality of the incisor (HP:0000676) | 1.87439103 |
| 96 | Narrow palate (HP:0000189) | 1.85346691 |
| 97 | 2-3 toe syndactyly (HP:0004691) | 1.85037413 |
| 98 | White forelock (HP:0002211) | 1.84107804 |
| 99 | Nasolacrimal duct obstruction (HP:0000579) | 1.83075274 |
| 100 | Infantile muscular hypotonia (HP:0008947) | 1.82792782 |
| 101 | Abnormality involving the epiphyses of the upper limbs (HP:0003839) | 1.81431900 |
| 102 | Morphological abnormality of the middle ear (HP:0008609) | 1.80617022 |
| 103 | Medial flaring of the eyebrow (HP:0010747) | 1.80353270 |
| 104 | Prominent nose (HP:0000448) | 1.80323345 |
| 105 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.79790418 |
| 106 | Abnormality of the lacrimal duct (HP:0011481) | 1.79593831 |
| 107 | Aplasia involving bones of the extremities (HP:0009825) | 1.78988523 |
| 108 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.78988523 |
| 109 | Aplasia of the phalanges of the hand (HP:0009802) | 1.78988523 |
| 110 | Acanthocytosis (HP:0001927) | 1.78048093 |
| 111 | Limb hypertonia (HP:0002509) | 1.77449113 |
| 112 | Acute lymphatic leukemia (HP:0006721) | 1.77441789 |
| 113 | Tracheomalacia (HP:0002779) | 1.76753762 |
| 114 | Vertebral arch anomaly (HP:0008438) | 1.76435077 |
| 115 | Termporal pattern (HP:0011008) | 1.75019536 |
| 116 | Insidious onset (HP:0003587) | 1.75019536 |
| 117 | Generalized tonic-clonic seizures (HP:0002069) | 1.74291805 |
| 118 | Obsessive-compulsive behavior (HP:0000722) | 1.74223570 |
| 119 | Abnormality of chromosome segregation (HP:0002916) | 1.74083381 |
| 120 | Intention tremor (HP:0002080) | 1.73551601 |
| 121 | Abnormality of the labia majora (HP:0012881) | 1.73305265 |
| 122 | Smooth philtrum (HP:0000319) | 1.73201718 |
| 123 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.72770364 |
| 124 | Neoplasm of the oral cavity (HP:0100649) | 1.72258768 |
| 125 | Abnormality of the calf musculature (HP:0001430) | 1.71699767 |
| 126 | Broad metatarsal (HP:0001783) | 1.71509354 |
| 127 | T lymphocytopenia (HP:0005403) | 1.71463137 |
| 128 | * Skull defect (HP:0001362) | 1.71172265 |
| 129 | Chromsome breakage (HP:0040012) | 1.70931351 |
| 130 | Large earlobe (HP:0009748) | 1.70664512 |
| 131 | Highly arched eyebrow (HP:0002553) | 1.69773782 |
| 132 | Neoplasm of the thyroid gland (HP:0100031) | 1.69733117 |
| 133 | Abnormality of the hepatic vasculature (HP:0006707) | 1.69702487 |
| 134 | Short metatarsal (HP:0010743) | 1.69413172 |
| 135 | Bronchomalacia (HP:0002780) | 1.68674495 |
| 136 | Overgrowth (HP:0001548) | 1.68280185 |
| 137 | Intellectual disability, moderate (HP:0002342) | 1.67996681 |
| 138 | Aplasia/Hypoplasia of metatarsal bones (HP:0001964) | 1.66877074 |
| 139 | Facial diplegia (HP:0001349) | 1.66637492 |
| 140 | Dysdiadochokinesis (HP:0002075) | 1.66627041 |
| 141 | Anal stenosis (HP:0002025) | 1.66621798 |
| 142 | Autoamputation (HP:0001218) | 1.66452529 |
| 143 | Labial hypoplasia (HP:0000066) | 1.66351820 |
| 144 | Hemiparesis (HP:0001269) | 1.65742760 |
| 145 | Cubitus valgus (HP:0002967) | 1.65462805 |
| 146 | Frequent falls (HP:0002359) | 1.65394001 |
| 147 | Abnormality of the renal medulla (HP:0100957) | 1.65360022 |
| 148 | Neoplasm of the adrenal cortex (HP:0100641) | 1.64109447 |
| 149 | Retinal dysplasia (HP:0007973) | 1.63961792 |
| 150 | Patchy hypopigmentation of hair (HP:0011365) | 1.63019909 |
| 151 | Truncal obesity (HP:0001956) | 1.62773796 |
| 152 | Gait imbalance (HP:0002141) | 1.62136295 |
| 153 | Genital tract atresia (HP:0001827) | 1.61866570 |
| 154 | Dysmetria (HP:0001310) | 1.61448002 |
| 155 | Nephrogenic diabetes insipidus (HP:0009806) | 1.60728510 |
| 156 | Dysmetric saccades (HP:0000641) | 1.60686424 |
| 157 | Difficulty running (HP:0009046) | 1.60615009 |
| 158 | Deeply set eye (HP:0000490) | 1.60385934 |
| 159 | Nephronophthisis (HP:0000090) | 1.60136941 |
| 160 | Hypothermia (HP:0002045) | 1.59774392 |
| 161 | Stereotypic behavior (HP:0000733) | 1.59768482 |
| 162 | * Abnormality of the nasolacrimal system (HP:0000614) | 1.59147088 |
| 163 | Dyschromatopsia (HP:0007641) | 1.59095778 |
| 164 | Tapered finger (HP:0001182) | 1.59057127 |
| 165 | Pheochromocytoma (HP:0002666) | 1.58822483 |
| 166 | Pulmonic stenosis (HP:0001642) | 1.57949043 |
| 167 | Hypoplastic iliac wings (HP:0002866) | 1.57804254 |
| 168 | Abnormality of the pubic bones (HP:0003172) | 1.57314950 |
| 169 | Coarse hair (HP:0002208) | 1.54548320 |
| 170 | Hip contracture (HP:0003273) | 1.53177909 |
| 171 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.53076355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 4.59671012 |
| 2 | MAP2K7 | 2.66908133 |
| 3 | NTRK3 | 2.54059149 |
| 4 | WNK3 | 2.52581727 |
| 5 | LATS1 | 2.39714396 |
| 6 | FGFR2 | 2.34751180 |
| 7 | OBSCN | 2.26820961 |
| 8 | NEK9 | 2.24888863 |
| 9 | MAP3K4 | 2.23410614 |
| 10 | CASK | 2.13361609 |
| 11 | ACVR1B | 2.12785677 |
| 12 | MARK1 | 2.12040714 |
| 13 | STK39 | 2.09010845 |
| 14 | STK38L | 2.06519732 |
| 15 | MKNK2 | 2.05629265 |
| 16 | AKT3 | 2.00911847 |
| 17 | INSRR | 1.91781078 |
| 18 | EIF2AK3 | 1.90855205 |
| 19 | BRSK2 | 1.86358815 |
| 20 | PIK3CG | 1.81153214 |
| 21 | PNCK | 1.80803694 |
| 22 | STK3 | 1.77753166 |
| 23 | NEK6 | 1.75446568 |
| 24 | CDK3 | 1.65602199 |
| 25 | MAP3K2 | 1.64807394 |
| 26 | MAPK13 | 1.62484714 |
| 27 | SGK2 | 1.61991342 |
| 28 | MKNK1 | 1.58130193 |
| 29 | WNK1 | 1.57919264 |
| 30 | OXSR1 | 1.56754295 |
| 31 | EPHA4 | 1.48673580 |
| 32 | FRK | 1.47880909 |
| 33 | NLK | 1.45477925 |
| 34 | SGK223 | 1.44281978 |
| 35 | SGK494 | 1.44281978 |
| 36 | SGK3 | 1.41708453 |
| 37 | PKN1 | 1.37042193 |
| 38 | CAMK1G | 1.32586803 |
| 39 | BRD4 | 1.24965993 |
| 40 | TRPM7 | 1.23944683 |
| 41 | STK24 | 1.21573230 |
| 42 | ZAK | 1.16754636 |
| 43 | CLK1 | 1.16189831 |
| 44 | CAMKK2 | 1.15884912 |
| 45 | TIE1 | 1.13367983 |
| 46 | NTRK2 | 1.11849745 |
| 47 | FER | 1.10466822 |
| 48 | PIK3CA | 1.08192573 |
| 49 | PRKCH | 1.06582306 |
| 50 | TEC | 1.06579745 |
| 51 | PRKCQ | 1.03227769 |
| 52 | MAP4K2 | 1.01267899 |
| 53 | MAP2K4 | 0.99703841 |
| 54 | EPHA3 | 0.99149145 |
| 55 | FES | 0.98122177 |
| 56 | PAK6 | 0.97475320 |
| 57 | TSSK6 | 0.95418309 |
| 58 | PLK2 | 0.95232061 |
| 59 | PRKCE | 0.95050839 |
| 60 | TXK | 0.94283687 |
| 61 | ERBB3 | 0.93628380 |
| 62 | CCNB1 | 0.92788907 |
| 63 | CDK12 | 0.86670672 |
| 64 | PRKAA2 | 0.86650426 |
| 65 | SIK2 | 0.86591534 |
| 66 | YES1 | 0.85995894 |
| 67 | MAPK15 | 0.85851072 |
| 68 | MAP3K13 | 0.85372582 |
| 69 | SGK1 | 0.85069255 |
| 70 | CDK5 | 0.84449146 |
| 71 | PDGFRB | 0.82006569 |
| 72 | MARK3 | 0.80618847 |
| 73 | KSR1 | 0.79483144 |
| 74 | CSNK1A1L | 0.78652960 |
| 75 | MINK1 | 0.77326605 |
| 76 | PTK2B | 0.76281637 |
| 77 | HIPK2 | 0.76004370 |
| 78 | CSNK1G2 | 0.74914028 |
| 79 | CDC42BPA | 0.74801215 |
| 80 | PAK3 | 0.73080543 |
| 81 | PRPF4B | 0.72829919 |
| 82 | IRAK1 | 0.71207085 |
| 83 | GRK5 | 0.70327473 |
| 84 | MARK2 | 0.70243303 |
| 85 | SCYL2 | 0.70091084 |
| 86 | UHMK1 | 0.69597670 |
| 87 | CAMK2D | 0.68252614 |
| 88 | JAK1 | 0.66773116 |
| 89 | CAMK2B | 0.66656405 |
| 90 | NUAK1 | 0.66606165 |
| 91 | ATM | 0.65046453 |
| 92 | PRKCG | 0.64391968 |
| 93 | MELK | 0.63446330 |
| 94 | RET | 0.63060706 |
| 95 | EPHB1 | 0.62614540 |
| 96 | MAPK7 | 0.62217862 |
| 97 | CAMK2A | 0.61259775 |
| 98 | PLK4 | 0.60983655 |
| 99 | DAPK2 | 0.60302331 |
| 100 | NEK1 | 0.59683158 |
| 101 | FYN | 0.58267744 |
| 102 | GRK7 | 0.58206354 |
| 103 | FGFR3 | 0.57521743 |
| 104 | ROCK2 | 0.57225975 |
| 105 | TTN | 0.57055221 |
| 106 | BMPR2 | 0.56108039 |
| 107 | RPS6KB1 | 0.55091584 |
| 108 | MST4 | 0.54725662 |
| 109 | CSNK1G1 | 0.54682821 |
| 110 | WNK4 | 0.53977935 |
| 111 | TAOK3 | 0.53761077 |
| 112 | CAMK4 | 0.53160140 |
| 113 | BMPR1B | 0.52656078 |
| 114 | PRKG1 | 0.51946451 |
| 115 | BCR | 0.51646693 |
| 116 | CAMK1D | 0.50837477 |
| 117 | PLK3 | 0.50773777 |
| 118 | ADRBK2 | 0.49845530 |
| 119 | MAP3K10 | 0.49683531 |
| 120 | STK4 | 0.48198178 |
| 121 | PRKAA1 | 0.48113766 |
| 122 | MAP3K7 | 0.47782516 |
| 123 | TNK2 | 0.47337710 |
| 124 | CSNK1G3 | 0.47273686 |
| 125 | DYRK1A | 0.47253526 |
| 126 | CSNK1D | 0.47027970 |
| 127 | PDGFRA | 0.46943953 |
| 128 | SRPK1 | 0.46396936 |
| 129 | MAP3K6 | 0.46194812 |
| 130 | * GSK3B | 0.45229726 |
| 131 | MAP3K14 | 0.44385530 |
| 132 | MAPK10 | 0.43989383 |
| 133 | NTRK1 | 0.42251404 |
| 134 | CDK6 | 0.42169521 |
| 135 | ADRBK1 | 0.42125137 |
| 136 | PHKG1 | 0.42100982 |
| 137 | PHKG2 | 0.42100982 |
| 138 | PBK | 0.41577484 |
| 139 | MET | 0.41175929 |
| 140 | FGFR1 | 0.39795482 |
| 141 | STK11 | 0.39214043 |
| 142 | PRKCB | 0.38921727 |
| 143 | ITK | 0.38888963 |
| 144 | WEE1 | 0.38393498 |
| 145 | PRKACB | 0.37175140 |
| 146 | PRKD1 | 0.37020673 |
| 147 | EGFR | 0.36684060 |
| 148 | TGFBR1 | 0.36487830 |
| 149 | CHEK1 | 0.33865023 |
| 150 | TTK | 0.33534052 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.70564039 |
| 2 | Morphine addiction_Homo sapiens_hsa05032 | 2.42247731 |
| 3 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.37178088 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.33315098 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.26382577 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.25988338 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.07710826 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 1.99154593 |
| 9 | Taste transduction_Homo sapiens_hsa04742 | 1.96989119 |
| 10 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.94498262 |
| 11 | Long-term depression_Homo sapiens_hsa04730 | 1.83465545 |
| 12 | Renin secretion_Homo sapiens_hsa04924 | 1.80351584 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.72277031 |
| 14 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.70206967 |
| 15 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.67863852 |
| 16 | Axon guidance_Homo sapiens_hsa04360 | 1.61545523 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.61169861 |
| 18 | Insulin secretion_Homo sapiens_hsa04911 | 1.60827924 |
| 19 | Salivary secretion_Homo sapiens_hsa04970 | 1.58496287 |
| 20 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.58232727 |
| 21 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.57842957 |
| 22 | Cocaine addiction_Homo sapiens_hsa05030 | 1.57500781 |
| 23 | Olfactory transduction_Homo sapiens_hsa04740 | 1.49600120 |
| 24 | ABC transporters_Homo sapiens_hsa02010 | 1.46079904 |
| 25 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.45698843 |
| 26 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.45154537 |
| 27 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.43539558 |
| 28 | Adherens junction_Homo sapiens_hsa04520 | 1.38447349 |
| 29 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.37410780 |
| 30 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.36822639 |
| 31 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.36357620 |
| 32 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.36103394 |
| 33 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.34850853 |
| 34 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.34584367 |
| 35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.32071474 |
| 36 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.31669408 |
| 37 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.30763095 |
| 38 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.29603704 |
| 39 | Basal transcription factors_Homo sapiens_hsa03022 | 1.29119704 |
| 40 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.24715476 |
| 41 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.23588328 |
| 42 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.22500138 |
| 43 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.22137343 |
| 44 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.21897929 |
| 45 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.20493737 |
| 46 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.17345224 |
| 47 | Phototransduction_Homo sapiens_hsa04744 | 1.16809866 |
| 48 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.15698493 |
| 49 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.14939710 |
| 50 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.14922205 |
| 51 | Cell cycle_Homo sapiens_hsa04110 | 1.13262902 |
| 52 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.12835742 |
| 53 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.12791641 |
| 54 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.12255180 |
| 55 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.10823111 |
| 56 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.10570410 |
| 57 | Gap junction_Homo sapiens_hsa04540 | 1.09066790 |
| 58 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.08872885 |
| 59 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.07307129 |
| 60 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.06784849 |
| 61 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.04535986 |
| 62 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.03952989 |
| 63 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.00743506 |
| 64 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.00652157 |
| 65 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.99427509 |
| 66 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.98851420 |
| 67 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.98282355 |
| 68 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.97930622 |
| 69 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.97715683 |
| 70 | Melanogenesis_Homo sapiens_hsa04916 | 0.97158407 |
| 71 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.96466243 |
| 72 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.96250058 |
| 73 | RNA degradation_Homo sapiens_hsa03018 | 0.94719718 |
| 74 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.94259702 |
| 75 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.93440402 |
| 76 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.93188368 |
| 77 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.93131917 |
| 78 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.90901027 |
| 79 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.90365070 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.89923997 |
| 81 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.89320017 |
| 82 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.86881868 |
| 83 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.86255548 |
| 84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84748567 |
| 85 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.83971737 |
| 86 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.83206811 |
| 87 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.83111885 |
| 88 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.82493323 |
| 89 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81398937 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.81124267 |
| 91 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.80601099 |
| 92 | Melanoma_Homo sapiens_hsa05218 | 0.80217522 |
| 93 | Glioma_Homo sapiens_hsa05214 | 0.79896083 |
| 94 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.79242138 |
| 95 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.78593022 |
| 96 | Tight junction_Homo sapiens_hsa04530 | 0.77644863 |
| 97 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.77501764 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.76500340 |
| 99 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.75464278 |
| 100 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.72809117 |
| 101 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.71946484 |
| 102 | Focal adhesion_Homo sapiens_hsa04510 | 0.69208261 |
| 103 | Prostate cancer_Homo sapiens_hsa05215 | 0.68340776 |
| 104 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.67638436 |
| 105 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.67440283 |
| 106 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.66965376 |
| 107 | Platelet activation_Homo sapiens_hsa04611 | 0.66870019 |
| 108 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.66727303 |
| 109 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.66234651 |
| 110 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65037783 |
| 111 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.64324461 |
| 112 | Alcoholism_Homo sapiens_hsa05034 | 0.62561084 |
| 113 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61444169 |
| 114 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.60473605 |
| 115 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59487668 |
| 116 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.57281070 |
| 117 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.56334990 |
| 118 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55789822 |
| 119 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.55321291 |
| 120 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.55137054 |
| 121 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.54873964 |
| 122 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.54007059 |
| 123 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53856332 |
| 124 | Measles_Homo sapiens_hsa05162 | 0.53624233 |
| 125 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53453212 |
| 126 | Endometrial cancer_Homo sapiens_hsa05213 | 0.52989964 |
| 127 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.52893580 |
| 128 | Lysine degradation_Homo sapiens_hsa00310 | 0.51720925 |
| 129 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.51448406 |
| 130 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48423791 |
| 131 | Colorectal cancer_Homo sapiens_hsa05210 | 0.48421640 |
| 132 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.48244584 |
| 133 | RNA transport_Homo sapiens_hsa03013 | 0.47194045 |
| 134 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.46711735 |
| 135 | Pathways in cancer_Homo sapiens_hsa05200 | 0.45248916 |
| 136 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43018799 |
| 137 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.42587866 |
| 138 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.42491092 |
| 139 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.41928389 |
| 140 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.41023827 |
| 141 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.40900992 |
| 142 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.40442766 |
| 143 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.38573730 |
| 144 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.38175194 |
| 145 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.37287391 |

